137 related articles for article (PubMed ID: 20821716)
1. Introduction to the special issue on environmental risk assessment of pharmaceuticals.
Knacker T; Metcalfe C
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():511-3. PubMed ID: 20821716
[No Abstract] [Full Text] [Related]
2. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
Laenge R; Steger-Hartmann T; Schweinfurth H
Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the accuracy and consistency of the Swedish environmental classification and information system for pharmaceuticals.
Agerstrand M; Rudén C
Sci Total Environ; 2010 May; 408(11):2327-39. PubMed ID: 20206966
[TBL] [Abstract][Full Text] [Related]
4. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.
Grung M; Källqvist T; Sakshaug S; Skurtveit S; Thomas KV
Ecotoxicol Environ Saf; 2008 Oct; 71(2):328-40. PubMed ID: 18068226
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
Kar S; Roy K
Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
[TBL] [Abstract][Full Text] [Related]
6. Targeting the environmental risk assessment of pharmaceuticals: Facts and fantasies.
Tarazona JV; Escher BI; Giltrow E; Sumpter J; Knacker T
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():603-13. PubMed ID: 19886731
[TBL] [Abstract][Full Text] [Related]
7. [Research progress of pharmaceutical and personal care products on ecological and human health].
Liu Y; Zhu L; Li J
Wei Sheng Yan Jiu; 2009 Mar; 38(2):237-40. PubMed ID: 19408672
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment of chemicals and pharmaceuticals in the pediatric population: a workshop report.
Pohl HR; van Engelen JG; Wilson J; Sips AJ
Regul Toxicol Pharmacol; 2005 Jun; 42(1):83-95. PubMed ID: 15896447
[TBL] [Abstract][Full Text] [Related]
9. Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals.
Küster A; Bachmann J; Brandt U; Ebert I; Hickmann S; Klein-Goedicke J; Maack G; Schmitz S; Thumm E; Rechenberg B
Regul Toxicol Pharmacol; 2009 Dec; 55(3):276-80. PubMed ID: 19607869
[TBL] [Abstract][Full Text] [Related]
10. A network-based approach to quantifying the impact of biologically active substances.
Hoeng J; Deehan R; Pratt D; Martin F; Sewer A; Thomson TM; Drubin DA; Waters CA; de Graaf D; Peitsch MC
Drug Discov Today; 2012 May; 17(9-10):413-8. PubMed ID: 22155224
[No Abstract] [Full Text] [Related]
11. The challenge: do pharmaceuticals present a risk to the environment, and what needs to be done to answer the question?
Sumpter JP
Environ Toxicol Chem; 2014 Sep; 33(9):1915. PubMed ID: 25138028
[No Abstract] [Full Text] [Related]
12. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals and personal care products: research needs for the next decade.
Brooks BW; Huggett DB; Boxall AB
Environ Toxicol Chem; 2009 Dec; 28(12):2469-72. PubMed ID: 19908931
[No Abstract] [Full Text] [Related]
14. Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals.
Ågerstrand M; Küster A; Bachmann J; Breitholtz M; Ebert I; Rechenberg B; Rudén C
Environ Pollut; 2011 Oct; 159(10):2487-92. PubMed ID: 21763042
[TBL] [Abstract][Full Text] [Related]
15. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
[TBL] [Abstract][Full Text] [Related]
16. Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization.
Schmitt H; Boucard T; Garric J; Jensen J; Parrott J; Péry A; Römbke J; Straub JO; Hutchinson TH; Sánchez-Argüello P; Wennmalm A; Duis K
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():588-602. PubMed ID: 19958048
[TBL] [Abstract][Full Text] [Related]
17. Unite to assess contaminant risk.
Novak PJ
Nature; 2011 Mar; 471(7340):578. PubMed ID: 21455163
[No Abstract] [Full Text] [Related]
18. Editorial on "Current approaches to trace analysis of pharmaceuticals and personal care products in the environment", by Wolfgang Buchberger.
Haddad PR
J Chromatogr A; 2011 Jan; 1218(4):602. PubMed ID: 21092972
[No Abstract] [Full Text] [Related]
19. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
20. Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.
Adler NE; Koschorreck J; Rechenberg B
Water Sci Technol; 2008; 57(1):91-7. PubMed ID: 18192745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
